The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Dudley J. Pennell

CMR Unit Royal Brompton Hospital

Sydney Street

London SW3 6NP

UK

[email]@ic.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • CMR Unit Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK. 1998 - 2012
  • Royal Brompton Hospital, London, UK. 2011 - 2012
  • Royal Brompton & Harefield NHS Foundation Trust, London, UK. 2012
  • Centre for Advanced Magnetic Resonance in Cardiology (CAMRIC), Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK. 2002
  • Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, UK. 2001

References

  1. Review of Journal of Cardiovascular Magnetic Resonance 2011. Pennell, D.J., Carpenter, J.P., Firmin, D.N., Kilner, P.J., Mohiaddin, R.H., Prasad, S.K. J. Cardiovasc. Magn. Reson (2012) [Pubmed]
  2. Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major. Pennell, D.J., Porter, J.B., Cappellini, M.D., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, C.K., Viprakasit, V., Elalfy, M.S., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A. Haematologica (2012) [Pubmed]
  3. Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major. Alpendurada, F., Smith, G.C., Carpenter, J.P., Nair, S.V., Tanner, M.A., Banya, W., Dessi, C., Galanello, R., Walker, J.M., Pennell, D.J. J. Cardiovasc. Magn. Reson (2012) [Pubmed]
  4. Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload. Pennell, D.J., Porter, J.B., Cappellini, M.D., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, C.K., Viprakasit, V., Elalfy, M.S., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A. Haematologica (2011) [Pubmed]
  5. Review of journal of cardiovascular magnetic resonance 2010. Pennell, D.J., Firmin, D.N., Kilner, P.J., Manning, W.J., Mohiaddin, R.H., Prasad, S.K. J. Cardiovasc. Magn. Reson (2011) [Pubmed]
  6. Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia. Pennell, D.J., Porter, J.B., Cappellini, M.D., El-Beshlawy, A., Chan, L.L., Aydinok, Y., Elalfy, M.S., Sutcharitchan, P., Li, C.K., Ibrahim, H., Viprakasit, V., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A. Blood (2010) [Pubmed]
  7. Cardiovascular magnetic resonance. Pennell, D.J. Circulation (2010) [Pubmed]
  8. Review of Journal of Cardiovascular Magnetic Resonance 2009. Pennell, D.J., Firmin, D.N., Kilner, P.J., Manning, W.J., Mohiaddin, R.H., Neubauer, S., Prasad, S.K. J. Cardiovasc. Magn. Reson (2010) [Pubmed]
  9. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Kirk, P., Roughton, M., Porter, J.B., Walker, J.M., Tanner, M.A., Patel, J., Wu, D., Taylor, J., Westwood, M.A., Anderson, L.J., Pennell, D.J. Circulation (2009) [Pubmed]
  10. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Pennell, D.J., Berdoukas, V., Karagiorga, M., Ladis, V., Piga, A., Aessopos, A., Gotsis, E.D., Tanner, M.A., Smith, G.C., Westwood, M.A., Wonke, B., Galanello, R. Blood (2006) [Pubmed]
  11. T2* magnetic resonance and myocardial iron in thalassemia. Pennell, D.J. Ann. N. Y. Acad. Sci. (2005) [Pubmed]
  12. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Pennell, D.J., Sechtem, U.P., Higgins, C.B., Manning, W.J., Pohost, G.M., Rademakers, F.E., van Rossum, A.C., Shaw, L.J., Yucel, E.K. Eur. Heart J. (2004) [Pubmed]
  13. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Pennell, D.J., Sechtem, U.P., Higgins, C.B., Manning, W.J., Pohost, G.M., Rademakers, F.E., van Rossum, A.C., Shaw, L.J., Yucel, E.K. J. Cardiovasc. Magn. Reson (2004) [Pubmed]
  14. Cardiovascular magnetic resonance: twenty-first century solutions in cardiology. Pennell, D.J. Clin. Med (2003) [Pubmed]
  15. Ventricular volume and mass by CMR. Pennell, D.J. J. Cardiovasc. Magn. Reson (2002) [Pubmed]
  16. Cardiovascular magnetic resonance. Pennell, D. Heart (2001) [Pubmed]
  17. The carvedilol hibernation reversible ischaemia trial, marker of success (CHRISTMAS) study. Methodology of a randomised, placebo controlled, multicentre study of carvedilol in hibernation and heart failure. Pennell, D.J., Ray, S.G., Davies, G., Burgess, M., Webster, J., Slomka, P., Atkinson, P., Cleland, J.G. Int. J. Cardiol. (2000) [Pubmed]
  18. Nuclear cardiology in the UK 1994: activity relative to Europe, USA, and British Cardiac Society targets. Pennell, D.J., Prvulovich, E., Tweddel, A., Caplin, J. Heart (1998) [Pubmed]
 
WikiGenes - Universities